Conference Coverage

This channel highlights DAIC's coverage of numerous key cardiology and medical imaging conferences each year. These include ACC, AHA, ASE, ASNC, EuroPCR, ECR, HIMSS, HRS, RSNA, SCAI, SCCT, TCT, and VIVA.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab

VIVA 2017 Late-breaking Clinical Trial Presentations

September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials ...

September 14, 2017

Videos | Structural Heart Occluders

VIDEO: Transcatheter Closure of Holes in the Heart

Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Sidra ...

September 13, 2017

News | Peripheral Artery Disease (PAD)

Philips Showcases Integrated Vascular Solutions at VIVA 2017

September 13, 2017 — Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference ...

September 13, 2017

News | Peripheral Artery Disease (PAD)

PQ Bypass Reports Positive Results for Detour System in Patients With Long Femoropopliteal Blockages

September 13, 2017 — A subset analysis of the DETOUR I clinical trial showed promising safety and effectiveness results ...

September 13, 2017

Vascular screening for abdominal aortic aneurysm, peripheral artery disease and hypertension during the VIVA Study in Denmark

News | Cardiac Diagnostics

Ultrasound Screening for Vascular Disease Saves One Life For Every 169 Patients Assessed

September 12, 2017 — A new screening program for vascular disease saves one life for every 169 men assessed, according ...

September 12, 2017

News | Pharmaceuticals

ORION 1 Trial Shows Inclisiran Lowers Bad Cholesterol Up to One Year

September 12, 2017 — Inclisiran lowers low-density lipoprotein (LDL, or “bad”) cholesterol for up to one year in ...

September 12, 2017

News | ESC

New FOURIER Analysis Examines How Low Cholesterol Can Safely Go

September 12, 2017 — Very aggressive reduction of LDL-cholesterol to ultra-low levels was associated with progressively ...

September 12, 2017

News | ESC

CANTOS Study Shows Reducing Inflammation Cuts Cardiovascular Disease, Lung Cancer Risk

September 12, 2017 — The IL-1β inhibitor canakinumab lowers the risk of cardiovascular disease and lung cancer risk by ...

September 12, 2017

Feature | Antiplatelet and Anticoagulation Therapies

COMPASS Trial Shows Rivaroxaban With Aspirin Improves Stable Cardiovascular Disease

September 12, 2017 — Rivaroxaban plus aspirin improves survival and reduces stroke and heart attack in patients with ...

September 12, 2017

Cardiovascular Research Foundation (CRF) announced the promotion of Juan F. Granada, M.D., as the foundation’s president and chief executive officer (CEO). CRF sponsors TCT.

Feature | Cath Lab

Cardiovascular Research Foundation Appointed Juan Granada as New President, CEO

September 12, 2017 – The Cardiovascular Research Foundation (CRF) announced the promotion of Juan F. Granada, M.D., as ...

September 12, 2017

TCT 2017 late-breaking trials and studies that will be presented on the latest cardiology technology clinical trials.

Feature | TCT

TCT 2017 Late-breaking Clinical Trial Presentations

November 9, 2017 — From numerous high-quality submissions, Transcatheter Cardiovascular Therapeutics (TCT) has selected ...

November 09, 2017

News | Cath Lab

Systolic Blood Pressure at Time of STEMI PCI May Predict In-Hospital Mortality

September 11, 2017 — Researchers have led a retrospective single-center study examining simple hemodynamic parameters ...

September 11, 2017

Abbott will end sales of the Absorb bioresorbable stent scaffold, pulling it off the market September 14, 2017.

Feature | Stents Bioresorbable | Dave Fornell

Abbott Will End Sales of Absorb Bioresorbable Stent

September 8, 2017 — Abbott Vascular has announced it will end commercial sales of its Absorb bioresorbable vascular ...

September 08, 2017

Giving oxygen to patients suffering a heart attack is not beneficial, according to the DETO2X-AMI study.

Feature | ESC

Oxygen Therapy Does Not Improve Survival in Heart Attack Patients

September 7, 2017 — Oxygen therapy does not improve survival in patients with heart attack symptoms, according to late ...

September 07, 2017

PURE study may cause revision of fat intake guidelines for cardiology.

Feature | ESC

PURE Study May Prompt Revisiting Dietary Fat Guidelines

September 7, 2017 — Researchers at the European Society of Cardiology (ESC) Congress called for a reconsideration of ...

September 07, 2017